Evidence map›Paper›PMID 38969604›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2024

Demographic factors associated with within-individual variability of lung function for adults with cystic fibrosis: A UK registry study.

Marco Palma, Ruth H Keogh, Siobhán B Carr, Rhonda Szczesniak, David Taylor-Robinson, Angela M Wood, Graciela Muniz-Terrera, Jessica K Barrett

Abstract read
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marco PalmaMRC Biostatistics Unit, University of Cambridge, United Kingdom. Electronic address: marco.palma@mrc-bsu.cam.ac.uk.
Ruth H KeoghDepartment of Medical Statistics, London School of Hygiene & Tropical Medicine, United Kingdom.
Siobhán B CarrRoyal Brompton Hospital, part of Guy's and St Thomas' NHS Foundation Trust, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom.
Rhonda SzczesniakDivisions of Biostatistics and Epidemiology and Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, United States; Department of Pediatrics, University of Cincinnati, United States.
David Taylor-RobinsonDepartment of Public Health, Policy and Systems, University of Liverpool, United Kingdom.
Angela M WoodCardiovascular Epidemiology Unit, University of Cambridge, United Kingdom.
Graciela Muniz-TerreraOhio University Heritage College of Osteopathic Medicine, United States; University of Edinburgh, United Kingdom.
Jessica K BarrettMRC Biostatistics Unit, University of Cambridge, United Kingdom.

Funding

R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosisR01HL141286 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SZCZESNIAK, RHONDA · 2019 to 2023
$2.3M
MRC MR/V020595/1NHLBI NIH HHS R01 HL141286
6 · The paper itself

Abstract

backgroundLung function is a key outcome used in the evaluation of disease progression in cystic fibrosis. The variability of individual lung function measurements over time (within-individual variability) has been shown to predict subsequent lung function changes. Nevertheless, the association between within-individual lung function variability and demographic and genetic covariates has not been quantified.

methodsWe performed a longitudinal analysis of data from a cohort of 7099 adults with cystic fibrosis (between 18 and 49 years old) from the UK cystic fibrosis registry, containing annual review data between 1996 and 2020. A mixed-effects location-scale model is used to quantify mean FEV

resultsMean FEV

conclusionsKey variables known to be linked with mean lung function in cystic fibrosis are also associated with an individual's lung function variability. This work opens new avenues to understand the role played by lung function variability in disease progression and its utility in predicting key outcomes such as mortality.

Indexed as

Cystic FibrosisRegistriesRespiratory Function TestsAdolescentAdultAge FactorsCystic Fibrosis Transmembrane Conductance RegulatorDisease ProgressionFemaleForced Expiratory VolumeHumansLongitudinal StudiesLungMaleMiddle AgedSex FactorsCystic Fibrosis Transmembrane Conductance RegulatorCystic fibrosisLung function variabilityMixed-effects location-scale model (MELSM)Within-individual variability

Identifiers

PMID38969604
PMCPMC11409769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.